Search Results 371-380 of 17420 for alopecia
... alopecia and =< grade 2 neuropathy, which are allowed; Participants with a prior or concurrent malignancy whose natural history or treatment (in the opinion ...
... alopecia and peripheral neuropathy =< grade 1 - Adequate excision: surgical removal of all clinically evident disease in the breast and lymph nodes as ...
... alopecia). Patients must not have had nitrosoureas or mitomycin C for 6 weeks prior to the initiation of study treatment. Radiation: Prior radiation therapy ...
52 (58%) women were diagnosed with polycystic ovary syndrome (PCOS). Women with APT were more likely to have male-pattern alopecia documented on physical ...
* Participants must have recovered to ≤ Grade 2 from all clinically significant toxicities related to prior therapies except alopecia. Key exclusion ...
... alopecia, and irreversible late sequelae of radiation therapy, must have resolved to Grade 0 or 1 per Common Terminology Criteria for Adverse Events (CTCAE ...
Understand more about this brain disorder that's the most common cause of dementia. Also learn about new tests and medicines on the market.
Any unresolved toxicity > Common Toxicity Criteria Grade 1 (except alopecia) from previous anticancer therapy (including radiotherapy); History or evidence ...
CTC grade 4 non-hematological Toxicity (except for alopecia, nausea, vomiting);; Significant liver function impairment - AST or ALT > 3 times the upper limit ...
Exceptions: Neuropathy, fatigue, and/or alopecia may be grade 1. Known active central nervous system (CNS) metastases. NOTE: Patients with previously ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.